Overview

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Status:
No longer available
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Open-label, continuation study
Details
Lead Sponsor:
Tracon Pharmaceuticals Inc.
Treatments:
Antibodies, Monoclonal
Axitinib
Bevacizumab
Capecitabine